• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

延迟病变中冠状动脉微血管功能障碍的性别差异对长期结局的影响。

Effect of Sex Difference of Coronary Microvascular Dysfunction on Long-Term Outcomes in Deferred Lesions.

机构信息

Division of Cardiology, Department of Internal Medicine, Ulsan Medical Center, Ulsan Hospital, Ulsan, Republic of Korea.

Division of Cardiology, Department of Internal Medicine, Ulsan Medical Center, Ulsan Hospital, Ulsan, Republic of Korea; Department of Mechanical Engineering, Inha University, Incheon, Republic of Korea.

出版信息

JACC Cardiovasc Interv. 2020 Jul 27;13(14):1669-1679. doi: 10.1016/j.jcin.2020.04.002. Epub 2020 Jun 24.

DOI:10.1016/j.jcin.2020.04.002
PMID:32593698
Abstract

OBJECTIVES

This study investigated the sex difference of long-term cardiovascular outcomes on coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) in patients with deferred coronary artery lesions.

BACKGROUND

Coronary microvascular dysfunction is associated with poorer long-term outcomes. It can be assessed by CFR and the IMR.

METHODS

The study prospectively enrolled 434 patients (133 women and 301 men) and analyzed CFR, IMR, fractional flow reserve, and quantitative coronary angiography. Clinical outcomes were assessed by major adverse cardiovascular event(s) (MACE) of cardiac death, myocardial infarction, and revascularization during 5 years of follow-up. The study protocol was approved by the Institutional Review Board or Ethics Committee at each participating center, and all patients provided written informed consent. The study protocol was in accordance with the Declaration of Helsinki.

RESULTS

Women had milder epicardial disease compared with men (fractional flow reserve: 0.91 [interquartile range (IQR): 0.87 to 0.96] vs. 0.90 [IQR: 0.86 to 0.95]; p = 0.037). IMR was similar between the sexes, but CFR was lower in women (2.69 [IQR: 2.08 to 3.90] vs. 3.20 [IQR: 2.20 to 4.31]; p = 0.006) due to a shorter resting mean transit time, whereas hyperemic mean transit times were similar. At 5-year follow-up, MACE was significantly lower in women compared with men (1.1% vs. 5.5%; p = 0.017). Sex, diabetes mellitus, and CFR were independent predictors for MACE for all patients. The risk of MACE was significantly higher in men with low versus high CFR (hazard ratio: 4.58; 95% confidence interval: 1.85 to 11.30; p = 0.011) which was not seen in women.

CONCLUSIONS

There was no sex difference in microvascular function by IMR. CFR was lower in women due to a higher resting coronary flow; however, long-term clinical outcomes in deferred lesions were better in women compared with men. (Clinical, Physiological and Prognostic Implication of Microvascular Status; NCT02186093).

摘要

目的

本研究旨在探讨延迟性冠状动脉病变患者中,冠状动脉血流储备(CFR)和微血管阻力指数(IMR)的长期心血管结局的性别差异。

背景

冠状动脉微血管功能障碍与较差的长期预后相关。可以通过 CFR 和 IMR 进行评估。

方法

该研究前瞻性纳入了 434 名患者(133 名女性和 301 名男性),并分析了 CFR、IMR、血流储备分数和定量冠状动脉造影。通过 5 年随访期间的主要不良心血管事件(MACE)(心脏死亡、心肌梗死和血运重建)评估临床结局。该研究方案经每个参与中心的机构审查委员会或伦理委员会批准,所有患者均提供书面知情同意。该研究方案符合《赫尔辛基宣言》。

结果

与男性相比,女性的表浅性疾病较轻(血流储备分数:0.91 [四分位距(IQR):0.87 至 0.96] 比 0.90 [IQR:0.86 至 0.95];p=0.037)。尽管 IMR 在两性之间相似,但 CFR 较低(2.69 [IQR:2.08 至 3.90] 比 3.20 [IQR:2.20 至 4.31];p=0.006),这是由于静息平均通过时间较短,而充血平均通过时间相似。在 5 年随访时,女性的 MACE 发生率明显低于男性(1.1%比 5.5%;p=0.017)。性别、糖尿病和 CFR 是所有患者 MACE 的独立预测因素。在 CFR 较低的男性中,MACE 的风险明显高于 CFR 较高的男性(危险比:4.58;95%置信区间:1.85 至 11.30;p=0.011),而在女性中则没有这种情况。

结论

在 IMR 方面,女性和男性的微血管功能没有性别差异。CFR 较低是由于静息状态下的冠状动脉血流较高所致;然而,与男性相比,延迟性病变的女性长期临床结局更好。(微血管状态的临床、生理和预后意义;NCT02186093)。

相似文献

1
Effect of Sex Difference of Coronary Microvascular Dysfunction on Long-Term Outcomes in Deferred Lesions.延迟病变中冠状动脉微血管功能障碍的性别差异对长期结局的影响。
JACC Cardiovasc Interv. 2020 Jul 27;13(14):1669-1679. doi: 10.1016/j.jcin.2020.04.002. Epub 2020 Jun 24.
2
Physiologic Characteristics and Clinical Outcomes of Patients With Discordance Between FFR and iFR.FFR 与 iFR 不相符患者的生理学特征和临床结局。
JACC Cardiovasc Interv. 2019 Oct 28;12(20):2018-2031. doi: 10.1016/j.jcin.2019.06.044. Epub 2019 Sep 25.
3
Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease.性别差异对无阻塞性冠状动脉疾病的心绞痛患者冠状动脉微血管功能障碍侵入性测量的影响。
JACC Cardiovasc Interv. 2015 Sep;8(11):1433-1441. doi: 10.1016/j.jcin.2015.03.045.
4
Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.经皮冠状动脉介入治疗后微循环阻力指数对非 ST 段抬高型急性冠状动脉综合征患者的预后价值。
Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1063-1074. doi: 10.1002/ccd.27529. Epub 2018 Feb 15.
5
Coronary Flow Reserve and Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis.冠心病患者的冠状动脉血流储备与微循环阻力。
J Am Coll Cardiol. 2016 Mar 15;67(10):1158-1169. doi: 10.1016/j.jacc.2015.12.053.
6
Coronary physiological assessment combining fractional flow reserve and index of microcirculatory resistance in patients undergoing elective percutaneous coronary intervention with grey zone fractional flow reserve.在接受灰区血流储备分数指导的择期经皮冠状动脉介入治疗患者中结合血流储备分数和微血管阻力指数的冠状动脉生理学评估。
Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1077-1087. doi: 10.1002/ccd.27570. Epub 2018 Mar 8.
7
Prognostic Implications of Resistive Reserve Ratio in Patients With Coronary Artery Disease.冠心病患者阻力储备比的预后意义。
J Am Heart Assoc. 2020 Apr 21;9(8):e015846. doi: 10.1161/JAHA.119.015846. Epub 2020 Apr 18.
8
Prognostic Implication of Thermodilution Coronary Flow Reserve in Patients Undergoing Fractional Flow Reserve Measurement.热稀释法测量冠状动脉血流储备在接受血流储备分数测量患者中的预后意义。
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1423-1433. doi: 10.1016/j.jcin.2018.05.005.
9
Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction.冠状动脉慢血流的目测估计与基于侵入性导丝的冠状动脉微血管功能障碍的诊断无关。
Circ Cardiovasc Interv. 2024 Jun;17(6):e013902. doi: 10.1161/CIRCINTERVENTIONS.123.013902. Epub 2024 Apr 7.
10
Comparative Significance of Invasive Measures of Microvascular Injury in Acute Myocardial Infarction.急性心肌梗死中微血管损伤的侵袭性检测手段的比较意义。
Circ Cardiovasc Interv. 2020 May;13(5):e008505. doi: 10.1161/CIRCINTERVENTIONS.119.008505. Epub 2020 May 15.

引用本文的文献

1
Myocardial perfusion and oxidative metabolism in healthy subjects: sex-specific insights from vasodilatory stress C-acetate PET.健康受试者的心肌灌注与氧化代谢:血管扩张应激C-乙酸盐PET的性别特异性见解
EJNMMI Res. 2025 Sep 2;15(1):116. doi: 10.1186/s13550-025-01311-w.
2
Ischemia with Non-Obstructive Coronary Artery Disease: Sex-Based Differences in Pathophysiology, Clinical Presentation, and Prognosis.非阻塞性冠状动脉疾病伴发的心肌缺血:病理生理学、临床表现及预后方面的性别差异
J Clin Med. 2025 Aug 14;14(16):5764. doi: 10.3390/jcm14165764.
3
Examining the Disproportionate Burden of Microvascular Disease in Women.
审视女性微血管疾病的不均衡负担。
Curr Atheroscler Rep. 2025 Jun 12;27(1):65. doi: 10.1007/s11883-025-01310-1.
4
[Diagnosis and treatment of patients with ANOCA. Consensus document of the SEC-Clinical Cardiology Association/SEC-Interventional Cardiology Association/SEC-Ischemic Heart Disease and Acute Cardiac Care Association/ SEC-Cardiovascular Imaging Association].[无阻塞性冠状动脉疾病患者的诊断与治疗。西班牙心脏病学会-临床心脏病学协会/西班牙心脏病学会-介入心脏病学协会/西班牙心脏病学会-缺血性心脏病与急性心脏护理协会/西班牙心脏病学会-心血管影像协会共识文件]
REC Interv Cardiol. 2023 Dec 20;6(2):106-116. doi: 10.24875/RECIC.M23000422. eCollection 2024 Apr-Jun.
5
Prognostic role of con-/discordant coronary flow reserve and microvascular resistance in coronary microvascular disease: a systematic review and network meta-analysis.冠状动脉微血管疾病中冠状动脉血流储备与微血管阻力一致/不一致的预后作用:一项系统评价和网状Meta分析
Open Heart. 2025 Jan 21;12(1):e003055. doi: 10.1136/openhrt-2024-003055.
6
Sex-specific mechanisms in vascular aging: exploring cellular and molecular pathways in the pathogenesis of age-related cardiovascular and cerebrovascular diseases.血管衰老中的性别特异性机制:探索与年龄相关的心血管和脑血管疾病发病机制中的细胞和分子途径。
Geroscience. 2025 Feb;47(1):301-337. doi: 10.1007/s11357-024-01489-2. Epub 2025 Jan 3.
7
Efficacy and safety of formula in the treatment of coronary microvascular disease: A randomized, double-blind, placebo-controlled clinical trial study.配方治疗冠状动脉微血管疾病的疗效和安全性:一项随机、双盲、安慰剂对照的临床试验研究。
Heliyon. 2024 Aug 3;10(16):e35747. doi: 10.1016/j.heliyon.2024.e35747. eCollection 2024 Aug 30.
8
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.心肌缺血综合征:一个新的命名法,旨在协调不断发展的国际临床实践指南。
Circulation. 2024 Nov 12;150(20):1631-1637. doi: 10.1161/CIRCULATIONAHA.123.065656. Epub 2024 Aug 30.
9
Traditional Cardiovascular Risk Factors and Coronary Microvascular Dysfunction in Women and Men: A Single-Center Study.传统心血管危险因素与男性和女性冠状动脉微血管功能障碍:一项单中心研究。
Cardiology. 2024;149(5):455-462. doi: 10.1159/000539102. Epub 2024 Apr 26.
10
Coronary Spasm Testing with Acetylcholine: A Powerful Tool for a Personalized Therapy of Coronary Vasomotor Disorders.乙酰胆碱激发试验:冠状动脉痉挛检测——冠状动脉血管舒缩障碍个体化治疗的有力工具
Life (Basel). 2024 Feb 22;14(3):292. doi: 10.3390/life14030292.